Molecular Formula | C14H24N2O4 |
Molar Mass | 284.351 |
Density | 1.15±0.1 g/cm3(Predicted) |
Melting Point | 183-185°C |
Boling Point | 508.7±50.0 °C(Predicted) |
Appearance | neat |
pKa | 4.13±0.60(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,2-8°C |
Physical and Chemical Properties | The bioactive Oseltamivir acid (GS 4071), an active metabolite of Oseltamivir phosphate, is an oral bioeffective and selective inhibitor of influenza virus neuraminidase (IC50=2 nM) and is active against influenza viruses A and B. |
Use | Product description Oseltamivir is an intermediate in the preparation of oseltamivir. Oseltamivir phosphate was developed and launched by Roche, Switzerland. Oseltamivir phosphate has a strong inhibitory activity of neuraminidase and is effective against influenza A and B viruses. |
Reference Show more | 1. Zang, Yichao, et al. "Development of a thin-layer chromatography bioautographic assay for neuraminidase inhibitors hyphenated with electrostatic field induced spray ionisation-mass spectrometry for identification of active Isatis indigotica root compounds. 2. [IF=4.946] Lai Yanni et al."3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase."Arch Pharm Res. 2020 May;43(5):489-502 3. [IF=4.759] Yichao Zang et al."Development of a thin-layer chromatography bioautographic assay for neuraminidase inhibitors hyphenated with electrostatic field induced spray ionisation-mass spectrometry for identification of active Isatis indigotica root compounds."J |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.517 ml | 17.584 ml | 35.168 ml |
5 mM | 0.703 ml | 3.517 ml | 7.034 ml |
10 mM | 0.352 ml | 1.758 ml | 3.517 ml |
5 mM | 0.07 ml | 0.352 ml | 0.703 ml |
EPA chemical information | 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, (3R,4R,5S)- (187227-45-8) |